Recurrent angioedema with normal C1-inhibitor: genetics determine the endotype
- Authors: Lebedkina M.S.1, Fomina D.S.1,2,3, Bobrikova E.N.1, Yukhnovskaya Y.D.1, Roppelt A.A.1, Kruglova T.S.1, Mukhina O.A.1, Mаrkina U.A.1, Nikitina E.A.1, Alekseeva Y.G.1, Karaulov A.V.2,4, Lysenko M.A.1,5
-
Affiliations:
- Moscow City Hospital 52
- The First Sechenov Moscow State Medical University (Sechenov University)
- Astana Medical University
- Life Improvement by Future Technologies (LIFT) Center
- The Russian National Research Medical University named after N.I. Pirogov
- Issue: Vol 22, No 1 (2025)
- Pages: 67-85
- Section: Case reports
- Submitted: 20.01.2025
- Accepted: 25.02.2025
- Published: 10.04.2025
- URL: https://rusalljournal.ru/raj/article/view/16993
- DOI: https://doi.org/10.36691/RJA16993
- ID: 16993
Cite item
Abstract
Hereditary angioedema with normal C1 esterase inhibitor is a rare genetic disorder characterized by periodical and unpredictable angioedema without quantitative and qualitative deficiency of C1-inhibitor. According to the modern classification, this disease can present as two different endotypes: bradykinin-mediated and endothelium dysfunction-associated. Diagnosis of this disease is complicated by the need to perform genetic screening because available laboratory tests (C1-inhibitor, its functionality, and C4 protein in blood plasma) are within normal values, functional molecular tests are not available, clinical data are limited to few cohorts and, for some genetic defects, to single clinical observations. Genetic examination of patients with recurrent angioedema expands the cohort of patients with hereditary angioedema and normal C1 esterase inhibitor.
The article describes 17 patients with hereditary angioedema with normal C1 esterase inhibitor who underwent treatment at a specialized center in Moscow. The bradykinin-mediated angioedema endotype was found in 13 patients (9 with mutation in PLG, 2 with mutation in FXII, and 2 with mutation in KNG1), and endothelium dysfunction-associated angioedema was diagnosed in 4 patients with mutation in MYOF (2 asymptomatic carriers). Currently, data on the clinical presentation, diagnosis, and therapy of patients are limited to single clinical cases and small clinical case series, thus further data collection is needed.
The publication contains unique data on the algorithm of diagnosis and selection of therapy in patients with angioedema and normal C1-inhibitor level.
Keywords
Full Text

About the authors
Marina S. Lebedkina
Moscow City Hospital 52
Author for correspondence.
Email: marina.ivanova0808@yandex.ru
ORCID iD: 0000-0002-9545-4720
SPIN-code: 1857-8154
MD
Россия, MoscowDarya S. Fomina
Moscow City Hospital 52; The First Sechenov Moscow State Medical University (Sechenov University); Astana Medical University
Email: daria_fomina@mail.ru
ORCID iD: 0000-0002-5083-6637
SPIN-code: 3023-4538
MD, Cand. Sci. (Med.), Assistant Professor
Россия, Moscow; Moscow; Astana, Republic of KazakhstanElena N. Bobrikova
Moscow City Hospital 52
Email: elena.bobrikova.69@mail.ru
ORCID iD: 0000-0002-6534-5902
SPIN-code: 5806-7260
MD
Россия, MoscowYulia D. Yukhnovskaya
Moscow City Hospital 52
Email: yukhyuliya@yandex.ru
ORCID iD: 0000-0002-0928-2054
SPIN-code: 1688-2416
Россия, Moscow
Anna A. Roppelt
Moscow City Hospital 52
Email: roppelt_anna@mail.ru
ORCID iD: 0000-0001-5132-1267
SPIN-code: 7249-4423
MD, Cand. Sci. (Medicine)
Россия, MoscowTatyana S. Kruglova
Moscow City Hospital 52
Email: surckova.t@yandex.ru
ORCID iD: 0000-0002-4949-9178
SPIN-code: 2884-5000
MD, Cand. Sci. (Medicine)
Россия, MoscowOlga A. Mukhina
Moscow City Hospital 52
Email: mukhina.o.a@gmail.com
ORCID iD: 0000-0002-3794-4991
SPIN-code: 7721-1941
Россия, Moscow
Ulyana A. Mаrkina
Moscow City Hospital 52
Email: itcher.md@bk.ru
ORCID iD: 0000-0002-6646-4233
SPIN-code: 6424-0012
Россия, Moscow
Ekaterina A. Nikitina
Moscow City Hospital 52
Email: katrin88866@gmail.com
ORCID iD: 0000-0002-0865-8355
SPIN-code: 3507-9106
Россия, Moscow
Yulia G. Alekseeva
Moscow City Hospital 52
Email: doctorajg5@gmail.com
ORCID iD: 0000-0002-4131-2436
SPIN-code: 5379-3655
Россия, Moscow
Aleksandr V. Karaulov
The First Sechenov Moscow State Medical University (Sechenov University); Life Improvement by Future Technologies (LIFT) Center
Email: drkaraulov@mail.ru
ORCID iD: 0000-0002-1930-5424
SPIN-code: 4122-5565
MD, Dr. Sci. (Medicine), Professor
Россия, Moscow; SkolkovoMariana A. Lysenko
Moscow City Hospital 52; The Russian National Research Medical University named after N.I. Pirogov
Email: gkb52@zdrav.mos.ru
ORCID iD: 0000-0001-6010-7975
SPIN-code: 3887-6250
MD, Dr. Sci. (Medicine), Professor
Россия, Moscow; MoscowReferences
- Jones D, Zafra H, Anderson J. Managing diagnosis, treatment, and burden of disease in hereditary angioedema patients with normal C1-esterase inhibitor. J Asthma Allergy. 2023;16:447–460. doi: 10.2147/JAA.S398333
- Riedl MA. Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract. 2013;1(5):427–432. doi: 10.1016/j.jaip.2013.06.004
- Reshef A, Buttgereit T, Betschel SD, et al. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus. J Allergy Clin Immunol. 2024;154(2):398–411.e1. doi: 10.1016/j.jaci.2024.03.024
- Vincent D, Parsopoulou F, Martin L, et al. Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency. J Allergy Clin Immunol Glob. 2024;3(2):100223. doi: 10.1016/j.jacig.2024.100223
- D’Apolito M, Santacroce R, Vazquez DO, et al. DAB2IP associates with hereditary angioedema: insights into the role of VEGF signaling in HAE pathophysiology. J Allergy Clin Immunol. 2024;154(3):698–706. doi: 10.1016/j.jaci.2024.05.017
- Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286–1289. doi: 10.1016/j.bbrc.2006.03.092
- Bork K, Wulff K, Steinmüller-Magin L, et al. Hereditary angioedema with a mutation in the plasminogen gene. Allergy. 2018;73(2):442–450. doi: 10.1111/all.13270
- Dickeson SK, Kumar S, Sun MF, et al. A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogen. Blood. 2022;139(18):2816–2829. doi: 10.1182/blood.2021012945
- Bork K, Wulff K, Rossmann H, et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin. Allergy. 2019;74(12):2479–2481. doi: 10.1111/all.13869
- Bafunno V, Firinu D, D’Apolito M, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141(3):1009–1017. doi: 10.1016/j.jaci.2017.05.020
- D’Apolito M, Santacroce R, Colia AL, et al. Angiopoietin-1 haploinsufficiency affects the endothelial barrier and causes hereditary angioedema. Clin Exp Allergy. 2019;49(5):626–635. doi: 10.1111/cea.13349
- Ariano A, D’Apolito M, Bova M, et al. A myoferlin gain-of-function variant associates with a new type of hereditary angioedema. Allergy. 2020;75(11):2989–2992. doi: 10.1111/all.14454
- Bork K, Wulff K, Möhl BS, et al. Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation. J Allergy Clin Immunol. 2021;148(4):1041–1048. doi: 10.1016/j.jaci.2021.01.01
- Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267–274. doi: 10.1016/j.amjmed.2005.09.064
- Bork K, Gül D, Hardt J, et al. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med. 2007;120(11):987–992. doi: 10.1016/j.amjmed.2007.08.021
- Bork K, Wulff K, Witzke G, et al. Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene. Orphanet J Rare Dis. 2020;15(1):52. doi: 10.1186/s13023-020-1334-8
- Marcos C, López Lera A, Varela S, et al. Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families. Ann Allergy Asthma Immunol. 2012;109(3):195–200e2. doi: 10.1016/j.anai.2012.05.022
- Piñero-Saavedra M, González-Quevedo T, Saenz de San Pedro B, et al. Hereditary angioedema with F12 mutation: сlinical features and enzyme polymorphisms in 9 Southwestern Spanish families. Ann Allergy Asthma Immunol. 2016;117(5):520–526. doi: 10.1016/j.anai.2016.09.001
- Bork K, Wulff K, Witzke G, Hardt J. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy. 2017;72(2):320–324. doi: 10.1111/all.13076
- Bouillet L, Boccon-Gibod I, Ponard D, et al. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol. 2009;103(5):448. doi: 10.1016/S1081-1206(10)60369-9
- Bova M, Suffritti C, Bafunno V, et al. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor. Allergy. 2020;75(6):1394–1403. doi: 10.1111/all.14160
- Veronez CL, Moreno AS, Constantino-Silva RN, et al. Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families. J Allergy Clin Immunol Pract. 2018;6(4):1209–1216.e8. doi: 10.1016/j.jaip.2017.09.025
- Belbezier A, Hardy G, Marlu R, et al. Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families. Allergy. 2018;73(11):2237–2239. doi: 10.1111/all.13543
- Hereditary angioedema. Clinical guidelines. 2024. Available at: https://diseases.medelement.com/disease/наследственный-ангиоотек-кр-рф-2024/18338. Accessed: 10.01.2025. (In Russ.).
- Sharma J, Jindal AK, Banday AZ, et al. Pathophysiology of hereditary angioedema (HAE) beyond the SERPING1 gene. Clin Rev Allergy Immunol. 2021;60(3):305–315. doi: 10.1007/s12016-021-08835-8
- Hu WG, Weng YM, Dong Y, et al. Apatinib in refractory radiation-induced brain edema: a case report. Medicine (Baltimore). 2017;96(46):e7358. doi: 10.1097/MD.0000000000007358
- Garcia JFB, Takejima P, Veronez CL, et al. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH. J Allergy Clin Immunol Pract. 2018;6(4):1406–1408. doi: 10.1016/j.jaip.2017.12.022
Supplementary files
